Yonsei University Health System (YUHS) and Korea International Cooperation Agency (KOICA) said they successfully completed the maternal and child health capacity building project in Senegal. KOICA is a n official development assistance (ODA) unit under the Ministry of Foreign Affairs.The program, wh
Bridge Biotherapeutics said on Thursday that it signed a memorandum of understanding (MOU) with Pinotbio to derive new therapeutic cancer candidates using antibody-drug conjugate (ADC) platform technology.Accordingly, Bridge Biotherapeutics will provide private anticancer targets, and Pinotbio will
As the government moves toward expanding insurance coverage for atopic dermatitis from adult to children and adolescent patients, negotiation will likely speed up to give benefits to injections and pills.For example, Sanofi is bargaining with the National Health Insurance Service (NHIS) to determine
Abion said on Wednesday that a joint animal study with Raphas to develop its Covid-19 DNA vaccine based on portable electro-attached microneedle patches under the support of the RIGHT Foundation’s technical acceleration award (TAA), has attained the first milestone showing strong antibody titers.As
Kolmar Korea said it would build an AI-backed mega plant in Sejong by 2024 to manufacture about 220 million units of cosmetics products annually to meet the growing global demand.The move comes as the Covid-19 pandemic is quickly becoming endemic worldwide and the global demand for makeup products,
Samil Pharmaceutical said on Wednesday that it launched Samsung Bioepis’ Amelivu (ingredient: Ranibizumab), a Lucentis biosimilar to treat macular degeneration, in Korea.Both companies had signed a domestic distribution and sales contract for Amelivu in June 2022. Amelivu is an ophthalmic disease tr
The supply price of all over-the-counter Tylenol (ingredient: acetaminophen) products sold at pharmacies and convenience stores will increase by about 18 percent.According to industry watchers, Johnson & Johnson Korea sent an official letter to pharmaceutical distributors regarding a price hike for
As the Ministry of Health and Welfare announced a list of newly certified “innovative pharmaceutical companies” companies for 2023, attention is drawn to new additions.On Thursday, the ministry said in a public notice that it had designated four more companies – Bridge Biotherapeutics, GI Innovation
SK Bioscience is recruiting executives from multinational pharmaceutical companies ahead of its full-scale overseas business expansion.The company said Friday it has recruited Richard Kensinger, a former research executive at global healthcare company Sanofi Pasteur, as the vice president of R&D pro
Medytox said on Friday that Gentix Limited, a subsidiary of its Chinese business partner Bloomage Biotechnology, filed a claim for damages against Medytox for contract violation with the Singapore International Arbitration Center (SIAC).According to Medytox’s public filing on Friday, the claim amoun
LG Chem said on Thursday that it invested 707.2 billion won ($571 million) to complete the acquisition of Aveo Pharmaceuticals, a U.S. oncology-specializing biopharma firm, through LG Chem Life Science Innovation Center, and will finalize the last details of the merger on Friday this week.The compan
Viatris Korea said it launched Dovprela (ingredient: pretomanid), a drug-resistant tuberculosis (TB) treatment, in January.Dovprela was developed by the TB Alliance, a non-profit organization that develops and delivers new TB treatments. The drug is produced and distributed through a global partners
GC Pharma said on Wednesday that its Sanfilippo Syndrome Type A treatment, jointly being developed with bio-venture Novel Pharma, has been designated as a Rare Pediatrics Disease (RPD) by the U.S. FDA.Sanfilippo syndrome (Type A), also known as mucopolysaccharidosis type IIIA (MPS IIIA), is a recess
Medytox said it will become the first Korean company to build a botulinum toxin finished product factory overseas.According to Medytox, it signed a Memorandum of Understanding (MOU) with Dubai Science Park, owned by Tecom Group, a state-run company in Dubai, to build a factory for finished BTX produ
Dato-DXd (datopotamab deruxtecan), jointly developed by Daiichi Sankyo and AstraZeneca, and NTLA-2001, co-developed by Intellia Therapeutics and Regeneron Pharmaceuticals, were evaluated to have high potential value among new drugs whose clinical results will come out this year.Kwak Seo-yeon, a seni
BMS Pharmaceutical Korea said on Tuesday that it released acute myeloid leukemia (AML) maintenance therapy Onureg (ingredient: azacitidine) in Korea on Monday.In March 2022, Onureg won domestic approval to treat AML patients who achieved complete remission (CR) or complete remission with incomplete
The Korea Biotechnology Industry Organization (KoreaBIO) said on Monday that the nation’s human vaccine trade balance recorded a deficit of $800 million (991 billion won) last year.As of 2022, the nation’s human vaccine exports stood at $941 million and imports were $1.74 billion.Australia was the l
Ahngook Pharm said the company and CMG Pharmaceutical have signed a contract to co-promote Amortan-R Tab, a three-drug combination treatment for hypertension and dyslipidemia. Under the agreement, Ahngook will sell Amortan-R in the domestic market. Amortan-R is a CCB-ARB-statin three-drug compound c
Bosulif Tab (bosutinib), Pfizer’s new treatment for Philadelphia chromosomal-positive chronic myeloid leukemia, has won domestic approval.The Ministry of Food and Drug Safety said Friday that it had approved three doses (100mg, 400mg, and 500 mg) of Pfizer Korea’s Bosulif (bosutinib) tablets.The Phi
NGeneBio said on Monday that it signed a technology transfer contract with The Catholic University of Korea Industry-Academic Cooperation Foundation and Dow Biomedica to commercialize a product that can check the variation of minimal residual disease (MRD).Acute myeloid leukemia (AML) is fast-growin